NCT00117052 - SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism | Biotech Hunter

Enrollment

673

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

February 28, 2006

Conditions

Secondary HyperparathyroidismEnd Stage Renal Disease

Interventions

DRUG

cinacalcet

All eligible subjects were assigned to receive once daily oral doses of cinacalcet, but were randomised in a 1:1 ratio to receive the drug either with the first meal after dialysis or during the dialysis visit on dialysis days.